View in EDS PDF Full Text

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.

Saved in:
Bibliographic Details
Title: RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Authors: Emde-Rajaratnam M; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Beck S; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany., Benes V; Europäisches Laboratorium für Molekularbiologie, GeneCore, Heidelberg, Germany., Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and St. Georg, Hamburg, Germany., Bertsch U; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany., Scheid C; Department I of Internal Medicine, University of Cologne, Cologne, Germany., Hänel M; Department of Internal Medicine III, Klinikum Chemnitz GmbH, Chemnitz, Germany., Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Hielscher T; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany., Raab MS; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany., Goldschmidt H; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany., Jauch A; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany., Maes K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., De Bruyne E; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Menu E; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., De Veirman K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Moreaux J; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France., Vanderkerken K; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Seckinger A; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium., Hose D; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
Source: Frontiers in immunology [Front Immunol] 2023 Nov 15; Vol. 14, pp. 1286700. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38035078
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Emde-Rajaratnam+M%22">Emde-Rajaratnam M</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Beck+S%22">Beck S</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.; Universitätsklinikum Heidelberg, Molekularpathologisches Zentrum, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Benes+V%22">Benes V</searchLink>; Europäisches Laboratorium für Molekularbiologie, GeneCore, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Salwender+H%22">Salwender H</searchLink>; Asklepios Tumorzentrum Hamburg, AK Altona and St. Georg, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bertsch+U%22">Bertsch U</searchLink>; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Scheid+C%22">Scheid C</searchLink>; Department I of Internal Medicine, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Hänel+M%22">Hänel M</searchLink>; Department of Internal Medicine III, Klinikum Chemnitz GmbH, Chemnitz, Germany.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Hielscher+T%22">Hielscher T</searchLink>; Deutsches Krebsforschungszentrum, Abteilung für Biostatistik, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Raab+MS%22">Raab MS</searchLink>; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Goldschmidt+H%22">Goldschmidt H</searchLink>; Universitätsklinikum Heidelberg, Medizinische Klinik V, Heidelberg, Germany.; Nationales Centrum für Tumorerkrankungen, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jauch+A%22">Jauch A</searchLink>; Universität Heidelberg, Institut für Humangenetik, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Maes+K%22">Maes K</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Bruyne+E%22">De Bruyne E</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Menu+E%22">Menu E</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22De+Veirman+K%22">De Veirman K</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Moreaux+J%22">Moreaux J</searchLink>; Institute of Human Genetics, UMR 9002 CNRS-UM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Vanderkerken+K%22">Vanderkerken K</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Seckinger+A%22">Seckinger A</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.<br /><searchLink fieldCode="AU" term="%22Hose+D%22">Hose D</searchLink>; Department of Hematology and Immunology, Myeloma Center Brussels & Labor für Myelomforschung, Vrije Universiteit Brussel (VUB), Jette, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Nov 15; Vol. 14, pp. 1286700. <i>Date of Electronic Publication: </i>2023 Nov 15 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38035078
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1286700
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1286700
    Titles:
      – TitleFull: RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Emde-Rajaratnam M
      – PersonEntity:
          Name:
            NameFull: Beck S
      – PersonEntity:
          Name:
            NameFull: Benes V
      – PersonEntity:
          Name:
            NameFull: Salwender H
      – PersonEntity:
          Name:
            NameFull: Bertsch U
      – PersonEntity:
          Name:
            NameFull: Scheid C
      – PersonEntity:
          Name:
            NameFull: Hänel M
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Hielscher T
      – PersonEntity:
          Name:
            NameFull: Raab MS
      – PersonEntity:
          Name:
            NameFull: Goldschmidt H
      – PersonEntity:
          Name:
            NameFull: Jauch A
      – PersonEntity:
          Name:
            NameFull: Maes K
      – PersonEntity:
          Name:
            NameFull: De Bruyne E
      – PersonEntity:
          Name:
            NameFull: Menu E
      – PersonEntity:
          Name:
            NameFull: De Veirman K
      – PersonEntity:
          Name:
            NameFull: Moreaux J
      – PersonEntity:
          Name:
            NameFull: Vanderkerken K
      – PersonEntity:
          Name:
            NameFull: Seckinger A
      – PersonEntity:
          Name:
            NameFull: Hose D
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 11
              Text: 2023 Nov 15
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1